Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05894694 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 27, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 30, 2024 to Dec 30, 2025v2 Show 7 more changesShow less
    • Start date changed from estimate of Jun 11, 2023 to Sep 27, 2023
    • Enrollment target: 318 to 320
    • Study completion date: Dec 30, 2024 to Dec 31, 2025
    • Interventions: palliative care group first-line scheme (Drug), palliative care group first-line scheme+compound kushen injection (Drug) to first-line scheme+compound kushen injection (Drug), palliative care group first-line scheme (Drug)
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: details revised at 2 of 3 entries
    • Study description shortened, about 3 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To clarify the effectiveness and safety of compound kushen injection in the treatment of advanced colorectal cancer.
Trial Details
NCT Number NCT05894694
Lead Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions
(from sponsor)		 Advanced Colorectal Carcinoma
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov